Systemic infections and inflammation affect chronic neurodegeneration
The DOI matches its Crossref record; 91 of the 93 references it cites were found in a registry or an index.
Abstract
It is well known that systemic infections cause flare-ups of disease in individuals with asthma and rheumatoid arthritis, and that relapses in multiple sclerosis can often be associated with upper respiratory-tract infections. Here we review evidence to support our hypothesis that in chronic neurodegenerative diseases such as Alzheimer's disease, with an ongoing innate immune response in the brain, systemic infections and inflammation can cause acute exacerbations of symptoms and drive the progression of neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [51]
In the citing paper
“gene expression by morphologically identical microglia can differ drastically contingent on context (Perry et al., 2007).”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Perry et al., 2007
In the citing paper
“Both of these phenomena can be explained by the concept of phenotypic heterogeneity of microglial cell populations100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“For example, chronic neurodegenerative diseases are associated with increasing numbers of microglia100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“Furthermore, with the deposition of Aβ, the phenotype of microglial cells becomes more neurotoxic118,146–148: they express several inflammatory cytokines, including IL-1β, IL-6, tumour necrosis factor (TNF) and CCL3 (also known as MIP1α)146.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [147]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 1×
“It is widely recognized that cells of the macrophage lineage exist in many states of activation, including pro-inflammatory, alternatively activated or even anti-inflammatory, following the ingestion of apoptotic cell”
BackgroundResting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Although the microglia are phenotypically downregulated, recent imaging studies in vivo show that these cells, even in their so-called resting state, are highly active, with their fine processes continually surveying their local microenvironmen”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Microglia are exquisitely sensitive to almost any disturbance of brain homeostasi”
BackgroundTracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728 · cited 1×
“First, inflammatory events in the thoracic abdominal cavity are signalled to the brain through vagal-nerve sensory afferents, and in turn the vagal efferent outflow might modify these inflammatory events through acetylcholine secretio”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Cited by
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
“Activation of the systemic innate immune system by infection may be involved in the early stages of AD pathogenesis (Perry et al., 2007).”
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
“However, chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
BackgroundSlavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
“Investigators have proposed that the microglia in the prion diseased brain are primed by the ongoing pathology and that a secondary stimulus, the signaling of systemic inflammation across the BBB, switches these cells to an aggressive phenotype (98).”
BackgroundSelf-citationAir pollution: mechanisms of neuroinflammation and CNS disease
Block, M. L., & Calderón-Garcidueñas, L. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.009 · Cited by 1,651
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Self-citationReactive Gliosis and the Multicellular Response to CNS Damage and Disease
Burda, J. E., & Sofroniew, M. V. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.034 · Cited by 1,438
“LPS and cytokines have powerful effects both on reactive microglia (Perry, 2010; Perry et al., 2007) and on reactive astrocytes (Hamby et al.”
Repertoire of microglial and macrophage responses after spinal cord injury
David, S., & Kroner, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3053 · Cited by 1,297
“Such microglial responses were seen in a mouse model of prion disease challenged with inoculation with LP”
BackgroundRole of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
“In addition, several studies (48,49) suggest that sustained inflammation from the periphery can cause proinflammatory cytokines in the CNS by crossing the bloodbrain barrier (BBB) and can contribute to cognitive decline in AD patients.”
BackgroundMitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging
Green, D. R., Galluzzi, L., & Kroemer, G. (2011) · Science · doi:10.1126/science.1201940 · Cited by 1,245
Danese, A., Moffitt, T. E., Harrington, H., Milne, B. J., Polanczyk, G., Pariante, C. M., Poulton, R., & Caspi, A. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.214 · Cited by 1,165
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139
Self-citationMicroglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
Self-citationA Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
“Thereore, over time, it has been suggested that the net effect of icroglial activation might be to further increase amyloid- depoition, perpetuating the neurodegenerative cascade (19,151).”
BackgroundThe role of exercise and PGC1α in inflammation and chronic disease
Handschin, C., & Spiegelman, B. M. (2008) · Nature · doi:10.1038/nature07206 · Cited by 1,083
“It should be noted that in addition to the local inflammation found in many neurodegenerative diseases, systemic inflammation further exacerbates these diseases and promotes the progression of neurodegeneratio”
Shemer, A., Grozovski, J., Tay, T. L., Tao, J., Volaski, A., Süß, P., Ardura-Fabregat, A., Gross-Vered, M., Kim, J.-S., David, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07548-5 · Cited by 1,052
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034
Inflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
“Activated microglia can be cytotoxic,(29) and their persistent activation might predispose to the development of neurodegenerative conditions such as Alzheimer disease in susceptible individuals, or provide the context in which such diseases take a more aggressive course.(12,30) In contrast, recent work suggests that…”
BackgroundInflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Innate immune memory in the brain shapes neurological disease hallmarks
Wendeln, A.-C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L. M., Wild, K., Skodras, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0023-4 · Cited by 956
Low-grade inflammation, diet composition and health: current research evidence and its translation
Minihane, A. M., Vinoy, S., Russell, W. R., Baka, A., Roche, H. M., Tuohy, K. M., Teeling, J. L., Blaak, E. E., Fenech, M., Vauzour, D., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515002093 · Cited by 916
“A normal part of the homeostatic signalling from the periphery to the brain, therefore, has the potential to have a profound impact on brain disease initiation or progression (44,45) .”
Review: Activation patterns of microglia and their identification in the human brain
Boche, D., Perry, V. H., & Nicoll, J. A. R. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12011 · Cited by 912
Self-citationHeterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
“For example, microglia around the cerebrovasculature (perivascular microglia) may be exposed to higher levels of IL-4 or IL-10 from encounters with activated T cells or regulatory T cells that have traversed the blood–brain barrier to enter the brain parenchyma around the blood vessels (Perry et al. 2007; Schwartz et…”
BackgroundDifferential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
“Despite this apparent uniformity, gene expression by morphologically identical microglia can differ drastically contingent on context (Perry et al., 2007).”
BackgroundWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Regulation of learning and memory by meningeal immunity: a key role for IL-4
Derecki, N. C., Cardani, A. N., Yang, C. H., Quinnies, K. M., Crihfield, A., Lynch, K. R., & Kipnis, J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091419 · Cited by 800
“Innate immune cells, both peripheral and CNS resident, were proposed as the source of proinflammatory cytokines that are secreted in response to any deviation from physiological homeostasis as a result of stress, disease, or injury (Perry et al., 2007).”
BackgroundInflammation: The Common Pathway of Stress-Related Diseases
Liu, Y.-Z., Wang, Y.-X., & Jiang, C.-L. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00316 · Cited by 800
“Activation of the systemic innate immune system by infection may participate in the early stages of AD pathogenesis (Perry et al., 2007).”
BackgroundMicroglia and neurodegeneration: The role of systemic inflammation
Cunningham, C. (2013) · Glia · doi:10.1002/glia.22350 · Cited by 769
“The terminology we adopted at that time (Perry et al., 2007) was derived from the original description of peripheral macrophage priming (Johnson et al.”
BackgroundMethodResultInfluentialSelf-citationPace, T. W. W., Negi, L. T., Adame, D. D., Cole, S. P., Sivilli, T. I., Brown, T. D., Issa, M. J., & Raison, C. L. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.011 · Cited by 748
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727
“Elderly, demented patients often have systemic comorbidities, such as pneumonia and other infections, and it has been shown that infectious disease outside the CNS can profoundly influence microglial activation [23, 27, 36].”
BackgroundImmune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
“Emerging evidence is beginning to suggest the latter: that altering peripheral inflammation during neurodegenerative disease can significantly alter disease course (Perry et al., 2007).”
BackgroundThe diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk
Pedersen, B. K. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179515 · Cited by 631
“Moreover, in addition to the neuroinflammation found in many neurodegenerative disorders, systemic inflammation may further exacerbate the progression of neurodegeneration (Perry et al. 2007).”
BackgroundMicroglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
“[10,11]).”
Perry, V. H., & Teeling, J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0382-8 · Cited by 590
“The microglia appear to have a relatively anti-inflammatory phenotype, which we have previously referred to as ‘benign’with regard to driving disease progression [65, 68].”
Self-citationMethamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
Microglial cell dysregulation in brain aging and neurodegeneration
von Bernhardi, R., Eugenín-von Bernhardi, L., & Eugenín, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00124 · Cited by 556
“Neurodegenerative diseases often have increased generation of RNS and ROS as an early event (Perry et al., 2002; Shi and Gibson, 2007), which can contribute to neuronal cell Frontiers in Aging Neuroscience | www.frontiersin.org 9 June 2015 | Volume 7 | Article 124 injury via various redox reactions…”
BackgroundThe outdoor air pollution and brain health workshop
Block, M. L., Elder, A., Auten, R. L., Bilbo, S. D., Chen, H., Chen, J.-C., Cory-Slechta, D. A., Costa, D., Diaz-Sanchez, D., Dorman, D. C., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.08.014 · Cited by 539
“, 2007) and to exacerbate neurodegenerative progression (Perry et al., 2007).”
BackgroundFunctions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Liu, J., Tan, Y., Cheng, H., Zhang, D., Feng, W., & Peng, C. (2022) · Aging and disease · doi:10.14336/ad.2022.0104 · Cited by 529
Cribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499
“However, chronic activation of the innate immune response in the brain is thought to contribute to neurodegeneration in AD [30,54].”
BackgroundExaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice
Yin, F., Banerjee, R., Thomas, B., Zhou, P., Qian, L., Jia, T., Ma, X., Ma, Y., Iadecola, C., Beal, M. F., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091568 · Cited by 480
“Such conditions are routine in the wild but not in our mouse colony (Perry et al., 2007; Björkqvist et al., 2008).”
BackgroundThe Meningeal Lymphatic System: A New Player in Neurophysiology
Da Mesquita, S., Fu, Z., & Kipnis, J. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.022 · Cited by 479
Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses
MacLullich, A. M. J., Ferguson, K. J., Miller, T., de Rooij, S. E. J. A., & Cunningham, C. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.05.019 · Cited by 447
“However, dysfunction of the stress response and heightened inflammatory states are common with ageing and neurodegeneration [29,31].”
BackgroundSelf-citationPostoperative Cognitive Dysfunction and Noncardiac Surgery
Evered, L. A., & Silbert, B. S. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003514 · Cited by 441
Tilstra, J. S., Clauson, C. L., Niedernhofer, L. J., & Robbins, P. D. (2011) · Europe PMC (PubMed Central) · Cited by 445
The Role of Exercise-Induced Myokines in Muscle Homeostasis and the Defense against Chronic Diseases
Brandt, C., & Pedersen, B. K. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/520258 · Cited by 430
“In addition, a number of neurodegenerative diseases are linked to a local inflammatory response in the brain (neuroinflammation) and systemic inflammation may further exacerbate the progression of neurodegeneration [28].”
BackgroundThe Science of Fatty Acids and Inflammation
Fritsche, K. L. (2015) · Advances in Nutrition · doi:10.3945/an.114.006940 · Cited by 430
“Excess chronic inflammation is an important etiologic factor in a wide range of common chronic diseases, including cardiovascular disease (4), diabetes (4), Alzheimer and other neurologic diseases (5), and cancer (6).”
BackgroundThe role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K.-S., Jung, H.-Y., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 427
Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415
Norden, D. M., Muccigrosso, M. M., & Godbout, J. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.028 · Cited by 413
“Last, these data are consistent with the clinical data that peripheral infections exaggerate cognitive decline in AD patients (Perry et al., 2007).”
BackgroundResultRegulation of Microglial Proliferation during Chronic Neurodegeneration
Gómez-Nicola, D., Fransen, N. L., Suzzi, S., & Perry, V. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4440-12.2013 · Cited by 407
“Moreover, microglia in prion disease are primed by the ongoing pathology, with an enhanced responsiveness to systemic inflammation (Perry et al., 2007).”
BackgroundSelf-citationMitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
“These activated microglia, found in close proximity to apoptotic oligodendrocytes, may release a range of mediators (Barnett and Prineas, 2004; Perry et al., 2007).”
BackgroundChen, J., Buchanan, J. B., Sparkman, N. L., Godbout, J. P., Freund, G. G., & Johnson, R. W. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.08.014 · Cited by 398
“Further, inflammatory cytokines can impair synaptic plasticity in the dentate gyrus (DG) and CA regions of the hippocampus (Bellinger et al., 1993; Cunningham et al., 1996; Tancredi et al., 2000; Hellstrom et al., 2005; Shaw et al., 2005; Perry et al., 2007 ) as well as disrupt hippocampal-dependent learning and memor…”
BackgroundDilger, R. N., & Johnson, R. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208108 · Cited by 391
“Namely, subsequent stimulation of the peripheral immune system causes primed microglial cells to be triggered, which culminates in a central response greater in both magnitude and duration than what would be predicted from classically activated microglia [5, 7].”
BackgroundAgeing and the telomere connection: An intimate relationship with inflammation
Zhang, J., Rane, G., Dai, X., Shanmugam, M. K., Arfuso, F., Samy, R. P., Lai, M. K. P., Kappei, D., Kumar, A. P., & Sethi, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2015.11.006 · Cited by 386
“be a major cause of ageing-associated diseases (Perry et al., 2007).”
BackgroundBrydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381
Thored, P., Heldmann, U., Gomes‐Leal, W., Gisler, R., Darsalia, V., Taneera, J., Nygren, J. M., Jacobsen, S. W., Ekdahl, C. T., Kokaia, Z., et al. (2009) · Glia · doi:10.1002/glia.20810 · Cited by 378
“It should be pointed out, though, that studies in a model of prion disease (Perry et al., 2007) have indicated that microglia can switch to a phenotype contributing to neuronal damage without morphological change (Perry et al., 2007).”
BackgroundResultInfluentialKempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P. A., Iyer, S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00216 · Cited by 365
“Systemic inflammation could induce behavioral and Frontiers in Cellular Neuroscience | www.frontiersin.org 2 July 2017 | Volume 11 | Article 216 cognitive changes and accelerate neurodegenerative disease pathogenesis (Perry, 2004; Perry et al., 2007; Cunningham et al., 2009).”
BackgroundJang, S., Kelley, K. W., & Johnson, R. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802865105 · Cited by 365
“Peripheral infection also exacerbated neurodegeneration in animal models of multiple sclerosis, Alzheimer’s disease, and prion disease by inducing an exaggerated inflammatory cytokine response in the brain (7).”
BackgroundExercise-induced myokines and their role in chronic diseases
Pedersen, B. K. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.010 · Cited by 362
“Moreover, in addition to the neuroinflammation found in many neurodegenerative disorders, systemic inflammation may further exacerbate the progression of neurodegeneration (Perry et al., 2007).”
Long-term cerebral consequences of sepsis
Widmann, C. N., & Heneka, M. T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70017-1 · Cited by 361
Microglia Function in Central Nervous System Development and Plasticity
Schafer, D. P., & Stevens, B. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020545 · Cited by 353
“Furthermore, a similar cytokine-mediated “priming” mechanism may also contribute to age-dependent memory loss associated with aging and neurodegenerative disease (Barrientos et al. 2006; Perry et al. 2007).”
BackgroundOmega-3 fatty acids and depression: scientific evidence and biological mechanisms
Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/313570 · Cited by 351
“Eicosanoids are biologically active lipid mediators produced from PUFAwhich play a role in inflammation and regulation of immune function [130].”
BackgroundMicroglia Function in Alzheimer’s Disease
Solito, E., & Sastre, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00014 · Cited by 349
“Understanding the routes of communication between peripheral immune responses and the brain has not been an easy challenge (Perry et al., 2007).”
BackgroundInfluentialMicroglial Dynamics and Role in the Healthy and Diseased Brain: A Paradigm of Functional Plasticity
Gomez-Nicola, D., & Perry, V. H. (2015) · The Neuroscientist · doi:10.1177/1073858414530512 · Cited by 340
“…be stimulated by factors like ATP and other nucleotides (Davalos and others 2005; Fontainhas and others 2011) or reduced by factors including CX3CL1 (Liang and others 2009), with other well-know modulatory systems like CD200, CD47, or GABA still not fully understood (Kettenmann and others 2011).”
BackgroundSelf-citationPott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008) · Brain · doi:10.1093/brain/awn101 · Cited by 335
“Microglial cells can be activated to different stages according to morphology, expressed markers and secreted products (Perry et al., 2007).”
BackgroundResultInsulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 328
“The interaction between low grade inflammation and insulin signalling is thought to be important in the evolution of both peripheral and neuronal insulin resistance, and in parallel with this, peripherally derived sources of pro-inflammatory molecules have also been shown to influence the pathogenesis of PD (Perry et…”
Periodontitis is associated with cognitive impairment among older adults: Analysis of NHANES-III
Noble, J. M., Borrell, L. N., Papapanou, P. N., Elkind, M. S. V., Scarmeas, N., & Wright, C. B. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.174029 · Cited by 324
“38 Alternatively, systemic inflammation has been hypothesised to directly influence expression of neurodegenerative disorders such as Alzheimer’s disease.(39) This study has several limitations other than the constraints of cross sectional analysis.”
BackgroundChronic microglial activation and progressive dopaminergic neurotoxicity
Block, M. L., & Hong, J.-S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351127 · Cited by 322
Brain morphology links systemic inflammation to cognitive function in midlife adults
Marsland, A. L., Gianaros, P. J., Kuan, D. C.-H., Sheu, L. K., Krajina, K., & Manuck, S. B. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.015 · Cited by 321
Bilbo, S. D., Block, C. L., Bolton, J. L., Hanamsagar, R., & Tran, P. K. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.002 · Cited by 319
“…iswell described in the neurodegeneration and aging literatures (Cunningham et al., 2009; Godbout and Johnson, 2006; Hennessy et al., 2017; Perry, 2004; Perry et al., 2007; Perry et al., 2010), and increasingly within the delirium literature as well (Maclullich et al., 2013; Sanders et al., 2014).”
Systemic infection, inflammation and acute ischemic stroke
McColl, B. W., Allan, S. M., & Rothwell, N. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.019 · Cited by 318
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Migliore, L., & Coppedè, F. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.10.011 · Cited by 317
“Moreover, there is also evidence for a role of ystemic infections and inflammation in AD pathogenesis [54].”
BackgroundMcColl, B. W., Rothwell, N. J., & Allan, S. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2674-08.2008 · Cited by 314
“This concept parallels the disease-modifying effects of systemic inflammation on chronic neurodegeneration (Perry et al., 2007) and highlights an important generic role for innate immune– brain interactions in acute and chronic neurological dysfunction.”
BackgroundContributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 306
“It has been proposed that the brain recognises cytokines as molecular signals of sickness, and induces symptoms of malaise, lassitude, fatigue, anhedonia, apathy, numbness, coldness, and reduced appetite and body temperature (Dantzer, 2009; Perry et al., 2007).”
BackgroundInfluentialNeuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303
Developmental neuroinflammation and schizophrenia
Meyer, U. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.11.003 · Cited by 300
“The author receives support from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement no. 259679.”
BackgroundMethodInfluentialGodbout, J. P., Moreau, M., Lestage, J., Chen, J., Sparkman, N. L., Connor, J. O., Castanon, N., Kelley, K. W., Dantzer, R., & Johnson, R. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301649 · Cited by 299
“The whole-brain analysis is justified by the fact that the brain cytokine system is diffused rather than spatially localized in the brain since its cellular basis is represented by perivascular macrophages and parenchymal microglia (Perry et al, 2007).”
BackgroundEmerging roles of innate and adaptive immunity in Alzheimer’s disease
Chen, X., & Holtzman, D. M. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.016 · Cited by 297
The influence of microglia on the pathogenesis of Parkinson's disease
Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296
Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment
Harry, G. J., & Kraft, A. D. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.10.1265 · Cited by 295
“The reader is directed to the following references for further reading on the influence of systemic inflammation of neuroinflammation [8,9,10,11].”
BackgroundLopez‐Rodriguez, A. B., Hennessy, E., Murray, C. L., Nazmi, A., Delaney, H. J., Healy, D., Fagan, S. G., Rooney, M., Stewart, E., Lewis, A., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12341 · Cited by 293
Self-citationSex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes
Dodiya, H. B., Kuntz, T., Shaik, S. M., Baufeld, C., Leibowitz, J., Zhang, X., Gottel, N., Zhang, X., Butovsky, O., Gilbert, J. A., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182386 · Cited by 288
“Peripheral inflammation plays a major role in central inflammation (Perry et al., 2007; Wendeln et al., 2018).”
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285
“Over the last decade the important concept has emerged that microglia, similar to other tissue macrophages, assume different phenotypes and perform specific effector functions depending on the precise nature of the stimulus, its intensity and duration (Olah et al., 2011; Perry et al., 2007; Tansey and Goldberg, 2010).”
BackgroundPatterson, S. L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.020 · Cited by 281
“It is very clear that a secondary immune challenge exacerbates cognitive decline in individuals already suffering from some degree of impairment, increasing the risk of developing delirium (or more gradual forms of cognitive decline) and worsening the prognosis (Cunningham et al., 2009; Perry et al., 2007; Perry and H…”
BackgroundInfluentialContribution of systemic inflammation to chronic neurodegeneration
Perry, V. H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0722-x · Cited by 277
“We have proposed that the microglia are ‘primed’ by the ongoing neurodegenerative disease and that the subsequent inflammatory challenge reveals this priming effect [81].”
BackgroundSelf-citationMicroglia and Memory: Modulation by Early-Life Infection
Williamson, L. L., Sholar, P. W., Mistry, R. S., Smith, S. H., & Bilbo, S. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3688-11.2011 · Cited by 276
“, systemic infection) is significantly exaggerated, compared with resting/quiescent glia that receive the same challenge (Perry et al., 2007).”
BackgroundInfluentialSkelly, D. T., Hennessy, E., Dansereau, M.-A., & Cunningham, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069123 · Cited by 274
“reviewed in detail elsewhere [3,34], the present discussion”
BackgroundSelf-citationNeuroinflammation and cognitive function in aged mice following minor surgery
Rosczyk, H. A., Sparkman, N. L., & Johnson, R. W. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.004 · Cited by 271
The multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
“We have consistently reported that IL-1β concentration is increased in the hippocampus of aged rats where it is inversely related to the ability of rats to sustain LTP [173, 199] and, although a correlation between these changes and expression of cell surface markers of microglial activation has been shown, these chan…”
BackgroundInflammation in Alzheimer's disease: relevance to pathogenesis and therapy
Zotova, E., Nicoll, J. A., Kalaria, R., Holmes, C., & Boche, D. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt24 · Cited by 259
Self-citationWang, Q., Davis, P. B., Gurney, M. E., & Xu, R. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12296 · Cited by 257
Priming Microglia for Innate Immune Memory in the Brain
Neher, J. J., & Cunningham, C. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.001 · Cited by 253
Self-citationLetenneur, L., Pérès, K., Fleury, H., Garrigue, I., Barberger-Gateau, P., Helmer, C., Orgogozo, J.-M., Gauthier, S., & Dartigues, J.-F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003637 · Cited by 252
“In several models of chronic neurodegenerative conditions, a pro-inflammatory response is observed [25] but it is kept under tight control, probably by appropriate anti-inflammatory mediators.”
Teeling, J. L., & Perry, V. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.031 · Cited by 252
Self-citationEtanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Butchart, J., Brook, L., Hopkins, V., Teeling, J., Püntener, U., Culliford, D., Sharples, R., Sharif, S., McFarlane, B., Raybould, R., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001617 · Cited by 248
“Musculoskeletal (sciatica, osteoarthritis, joint stiffness, back pain, thoracic vertebral fracture, muscle weakness) 1 (1) 5 (3)”
InfluentialSelf-citation
Metadata
- Authors
- Perry, V. H., Cunningham, C., & Holmes, C.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Perry, V. Hugh
- Venue
- Nature Reviews Immunology
- Published
- 2007-01-15
- Volume
- 7
- Issue
- 2
- Pages
- 161-167
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970606114
- Cited by
- 1,027
- References
- 93
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 61 · 2023: 34 · 2022: 52 · 2021: 69 · 2020: 73 · 2019: 50 · 2018: 56 · 2017: 44 · 2016: 54 · 2015: 63 · 2014: 66 · 2013: 58 · 2012: 62
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- systemic infection, inflammation, chronic neurodegeneration, neuroinflammation, Alzheimer's disease, innate immune response, disease exacerbation, multiple sclerosis relapse, upper respiratory tract infection
- MeSH terms
- Aging, Animals, Brain, Communicable Diseases, Humans, Inflammation, Microglia, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.